# Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Epidemiological Studies of Reproductive and Developmental Outcomes in Denmark: Supplement on Congenital Cytomegalovirus Infection among Children with Hearing Loss, Program Announcement Number (PA) DD 07-001
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.
*Time and Date:* 8 a.m.-5 p.m., July 2, 2008 (Closed).
*Place:* Teleconference.
*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to “Epidemiological Studies of Reproductive and Developmental Outcomes in Denmark: Supplement on Congenital Cytomegalovirus Infection among Children with Hearing Loss, PA DD 07-001.”
*Contact Person for More Information:* K. Ann Berry, Senior Scientist, CDC, 1600 Clifton Road, NE., Mailstop E20, Atlanta, GA 30333, Telephone (404) 498-2503.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: June 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.